Orbit Genomics, Inc. has been named one of the 30 finalists for the Pepperdine Most Fundable Companies Competition, chosen from over 2,300 applicants. We would like to thank Pepperdine and the judges for this competition in recognizing the company for its efforts in developing highly accurate genomics tests for oncology, cardiovascular, longevity and other indications.
